Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug
Plus, news about Merck, Vyne Therapeutics, Verastem Oncology, Oryzon Genomics, and Azitra: Eli Lilly asks European regulator to reassess its Alzheimer’s drug: The European Medicines Agency's human medicines committee in March
Plus, news about Merck, Vyne Therapeutics, Verastem Oncology, Oryzon Genomics, and Azitra:
Eli Lilly asks European regulator to reassess its Alzheimer’s drug: The European Medicines Agency's human medicines committee in March
